Fig. 42From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseMolecular structures of dimethylamino coumarin derivatives C42 and C43Back to article page